BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 6730039)

  • 1. [The pill and cancer of the breast and cervix uteri].
    Pedersen A
    Ugeskr Laeger; 1984 Apr; 146(14):1063-6. PubMed ID: 6730039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Royal College of General Practitioners' Oral Contraception Study: some recent observations.
    Kay CR
    Clin Obstet Gynaecol; 1984 Dec; 11(3):759-86. PubMed ID: 6509858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weighing the evidence on the pill and breast cancer.
    Johnson JH
    Fam Plann Perspect; 1989; 21(2):89-92. PubMed ID: 2653859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Researchers can now investigate long-term effects of OCs on cancer.
    Rubin GL; Peterson HB
    Contracept Technol Update; 1985 Jan; 6(1):7-12. PubMed ID: 12279918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pill and cancer--IPPF response.
    IPPF Med Bull; 1983 Dec; 17(6):1-2. PubMed ID: 12279693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral contraceptives and cancer.
    FDA Drug Bull; 1984 Apr; 14(1):2-3. PubMed ID: 6734989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptive risks: a realistic appraisal.
    Bressler R; Durand JL
    Drug Ther (NY); 1979 Oct; 9(10):81-95. PubMed ID: 12279276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women.
    Gammon MD; Hibshoosh H; Terry MB; Bose S; Schoenberg JB; Brinton LA; Bernstein JL; Thompson WD
    Cancer Epidemiol Biomarkers Prev; 1999 May; 8(5):413-9. PubMed ID: 10350436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New discoveries on oral contraceptives and risk of breast cancer. International data show a moderate increase in risk].
    Persson I
    Lakartidningen; 1996 Dec; 93(50):4613-6. PubMed ID: 8999253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risks of oral contraceptive use in women over 35.
    Stenchever MA
    J Reprod Med; 1993 Dec; 38(12 Suppl):1030-5. PubMed ID: 8120860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cancers of the uterus and ovary and the contraceptive pill].
    Vessey MP
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):339-43. PubMed ID: 12280204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill.
    Vessey MP; Lawless M; McPherson K; Yeates D
    Lancet; 1983 Oct; 2(8356):930-4. PubMed ID: 6138502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Oral contraceptives and cancer].
    Ludwig H
    Schweiz Rundsch Med Prax; 1989 Nov; 78(46):1273-5. PubMed ID: 2814116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of thrombotic risk factors when oral contraceptives are prescribed. A control-only study.
    Lidegaard O
    Acta Obstet Gynecol Scand; 1997 Mar; 76(3):252-60. PubMed ID: 9093141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on cancer risk and oral contraceptives.
    Engel NS
    MCN Am J Matern Child Nurs; 1990; 15(1):37. PubMed ID: 2105427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oral contraceptives: recent safety studies (author's transl)].
    Edgren RA
    Contracept Fertil Sex (Paris); 1983 Sep; 11(9):975-83. PubMed ID: 12279633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraceptives and breast cancer.
    Gay JW; Cardwell MS
    Mo Med; 1990 Oct; 87(10):763-7. PubMed ID: 2259330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Possible link between long-term oral contraceptive use and cervical cancer].
    Perspect Int Planif Fam; 1987; (Spec No):40-1. PubMed ID: 12269054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraceptives and cancer of the reproductive organs.
    Huezo C
    IPPF Med Bull; 1985 Dec; 19(6):3-4. PubMed ID: 12267511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
    Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.